Person profile

Public information reviewed

Wenbin Jiang, Ph.D.

Role

Chief Executive Officer and President at Cytek Biosciences, Inc. (NASDAQ: CTKB)

Board role

Chief Executive Officer, President and Director · Cytek Biosciences, Inc. (NASDAQ: CTKB)

Board role

Director · West Pharmaceutical Services (NYSE: WST)

West Pharmaceutical Services (NYSE: WST)

Director · Current mandate

Director · Board · Executive
FollowSave PDF
More
Reports & analysis (Check report directory)Alpha Eval
Evidence records
8
Profile ownership
Not yet claimed
Record reviewed
Sep 6, 2026
View evidence

Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
32 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Wenbin Jiang serves as Chief Executive Officer, President and Director of Cytek Biosciences. Further biographical details are referenced in the proxy's director election section.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Executive appointments

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Chief Executive Officer, President and Director

Cytek Biosciences, Inc.

Current · start date not disclosed

Confirmed by public sourceView source

Director

West Pharmaceutical Services

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Cytek Biosciences, Inc.

Open Cytek Biosciences, Inc. profile →

Chief Executive Officer, President and Director at Cytek Biosciences, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

Chief Executive Officer and President at Cytek Biosciences, Inc.

Start not stated → End not stated

current · source reported

Observed: 2026-09-25

Cytek Biosciences,…Cytek Biosciences, Inc.West Pharmaceutica…West Pharmaceutical ServicesWenbin Jiang, Ph.D.

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingCTKB DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 2 · Sec FilingIRON DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 3 · Sec FilingTVTX DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 4 · Sec FilingWest Pharmaceutical Services, Inc. director board sourceSupports Board membership, Committee assignments, Board independence.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:william-f-feehery-phd
Record version
public-0

Published evidence records

8 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. CTKB DEF 14A executive officers

    sec filing · Source published: Apr 28, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Cytek Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Executive Officer, President and Director · Claim reviewed: May 15, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 15, 2026

  2. IRON DEF 14A executive officers

    sec filing · Source published: Apr 28, 2026 · Retrieved: May 4, 2026

    Supports 2 claims
    • Executive company: Executive at Disc Medicine, Inc. · Claim reviewed: May 4, 2026
    • Executive title: Executive title: Named Executive Officer · Claim reviewed: May 5, 2026

  3. Open source

    sec def 14a · Source published: Apr 28, 2026 · Retrieved: Sep 6, 2026

    Supports 3 claims
    • Professional Role: Chief Executive Officer, President and Director at Cytek Biosciences, Inc. · Claim reviewed: Sep 6, 2026
    • Professional Role: Chief Executive Officer and President at Cytek Biosciences, Inc. · Claim reviewed: Sep 6, 2026
    • Executive title: Executive title: Chief Executive Officer and President · Claim reviewed: Sep 6, 2026

  4. TVTX DEF 14A executive officers

    sec filing · Source published: Apr 6, 2026 · Retrieved: May 5, 2026

    Supports 2 claims
    • Executive company: Executive at Travere Therapeutics, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: Named Executive Officer · Claim reviewed: May 5, 2026

  5. West Pharmaceutical Services, Inc. director board source

    sec filing · Source published: Mar 12, 2026 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of West Pharmaceutical Services, Inc. · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  6. Open source

    sec filing · Source published: Mar 12, 2026 · Retrieved: May 3, 2026

    Supports 1 claim
    • Professional Role: Director at West Pharmaceutical Services · Claim reviewed: Sep 6, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Cytek Biosciences, Inc. · Claim reviewed: Sep 6, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of West Pharmaceutical Services, Inc. · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board independence · Source reportedIndependent director1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · Source reportedServes on the board of Cytek Biosciences, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · CorroboratedServes on the board of West Pharmaceutical Services, Inc.Supported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Cytek Biosciences, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Disc Medicine, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive company · Source reportedExecutive at Travere Therapeutics, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 5, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 5, 2026

Executive title · Source reportedExecutive title: Chief Executive Officer and President1 source
Verification
Source reported
Confidence
95%
Last reviewed
Sep 6, 2026
Executive title · Source reportedExecutive title: Chief Executive Officer, President and Director1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · CorroboratedExecutive title: Named Executive OfficerSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 5, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 5, 2026

Technology background · Source reportedTechnology background reported in filings1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources8 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

    Supports: Executive company · Executive title

  3. https://www.sec.gov/Archives/edgar/data/1831915/000114036126017479/ny20066946x1_def14a.htm

    Sec Def 14a · Tier not stated · Reviewed Sep 6, 2026

    Supports: Chief Executive Officer, President and Director at Cytek Biosciences, Inc. (NASDAQ: CTKB) · Chief Executive Officer and President at Cytek Biosciences, Inc. (NASDAQ: CTKB) · Executive title

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 5, 2026

    Supports: Executive company · Executive title

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Board independence

  6. https://www.sec.gov/Archives/edgar/data/105770/000110465926026778/wst-20260504xdef14a.htm

    Sec Filing · Tier not stated · Reviewed May 3, 2026

    Supports: Director at West Pharmaceutical Services (NYSE: WST)

  7. https://www.sec.gov/Archives/edgar/data/1831915/000114036126017479/ny20066946x1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/105770/000110465926026778/wst-20260504xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership